Stay updated on SL-401 Combo in AML/MDS/BPDCN Clinical Trial

Sign up to get notified when there's something new on the SL-401 Combo in AML/MDS/BPDCN Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SL-401 Combo in AML/MDS/BPDCN Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Locations section updated to list California, Massachusetts, and Texas as study sites; prior revision removed HHS Vulnerability Disclosure and older location entries.
    Difference
    0.4%
    Check dated 2025-12-24T13:50:35.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    42 days ago
    Change Detected
    Summary
    The page adds a note that PubMed publications are auto-filled and may not be about the study, and updates the revision label from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T13:51:14.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Removed a site-wide notice about a lapse in government funding and NIH operating status from this page, and the study details, eligibility criteria, and other essential content remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-18T07:22:22.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The study contact section was updated to include a backup contact (Veronica Zehnder) with email and phone, and old contact details were removed.
    Difference
    0.9%
    Check dated 2025-11-11T03:14:54.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    No significant changes detected; the observed differences are minor UI/formatting updates that do not affect the study's core information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T21:30:13.000Z thumbnail image
  9. Check
    92 days ago
    Change Detected
    Summary
    Version updated to v3.2.0 with a government funding notice; removal of the term 'CD4+/CD56+ hematodermic neoplasm' from the content.
    Difference
    3%
    Check dated 2025-10-06T07:55:26.000Z thumbnail image

Stay in the know with updates to SL-401 Combo in AML/MDS/BPDCN Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SL-401 Combo in AML/MDS/BPDCN Clinical Trial page.